VolitionRX News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

20.03.24	VolitionRx Names Andrew Retter Chief Medical Officer (RTTNews)
17.02.23	VolitionRx Prices Public Offering Of $7.525 Mln Of Shares At $1.75/shr (RTTNews)
17.01.23	Pre-market Movers: MGOL, ACER, BTCM, INDO, TKC… (RTTNews)
20.10.22	VolitionRx Signs Global Supply Deal For Nu.Q Vet Cancer Test (RTTNews)
15.06.22	Pre-market Movers: REV, ASTL, VNRX, VORB, GGR… (RTTNews)
29.03.22	Volition Signs Exclusive $28 million License and Supply Agreement with Heska Corporation to Distribute Nu.Q® Vet Cancer Screening Test at the Point of Care (PR Newswire)
11.08.21	VolitionRx Limited Announces Second Quarter 2021 Financial Results and Business Update (PR Newswire)
04.08.21	VolitionRx Limited Schedules Second Quarter 2021 Earnings Conference Call and Business Update (PR Newswire)
22.07.21	Volition's Nu.Q® NETs Assay Demonstrates Promising Results in COVID-19 Risk Stratification and Disease Monitoring (PR Newswire)
14.07.20	Stock Alert: VolitionRx Shares Rally 80% In Premarket On COVID-19 Triage Test Data (RTTNews)
14.07.20	VolitionRx: Nu.Q Shows Correlation With Disease Severity In COVID-19 Patients (RTTNews)
23.04.20	Volition Files Patent For Nu.Q COVID-19 Triage Test (RTTNews)
26.09.19	5 Top Gainers In Healthcare Sector Today (OVID, PHAS, TXMD…) (RTTNews)
25.09.19	5 Top Gainers In Healthcare Sector Today (OVID, ZEAL, VCNX…) (RTTNews)
11.07.19	5 Top Gainers In Healthcare Sector (TRXC, OHRP, VNRX...) (RTTNews)
14.08.18	XBIO To Report Phase 2 Data This Year, VNRX Abuzz, ATRS To Face FDA In Sep (RTTNews)
14.05.18	VolitionRx Limited to Attend the Bank of America Merrill Lynch 2018 Health Care Conference from May 15-17, 2018 (PR Newswire)
10.05.18	VolitionRx Limited Announces First Quarter 2018 Financial Results and Business Update (PR Newswire)
09.05.18	VolitionRx Signs a Global Sales and Distribution Agreement with Active Motif for its new RUO kits (PR Newswire)
08.05.18	2018 Inter Lubric China to Be Held in Shanghai Between November 7-9 (PR Newswire)
04.05.18	VolitionRx Limited Schedules First Quarter 2018 Earnings Conference Call and Business Update (PR Newswire)
07.03.18	VolitionRx Appoints Harvard Professor, Dr. Lee-Jen Wei to Its Scientific Advisory Board (PR Newswire)
01.03.18	VolitionRX Limited Announces Full Fiscal Year 2017 Financial Results and Business Update (PR Newswire)
28.02.18	VolitionRx Limited Schedules Full Year 2017 Earnings Conference Call and Business Update (PR Newswire)
26.02.18	VolitionRx Limited Announces Interim Results from 680-Subject Clinical Trial in Colorectal Cancer (PR Newswire)
22.02.18	China Distance Education Holdings Limited to Report First Quarter Fiscal Year 2018 Financial Results on Wednesday, March 7, 2018 (PR Newswire)
05.02.18	VolitionRX Announces the Successful Conclusion of the Logistics and Pathway Design Study Conducted in Denmark. (PR Newswire)
03.01.18	VolitionRx Limited Releases Letter to Shareholders Including Status Update on Key Clinical Milestone (PR Newswire)
19.12.17	Logicalis US Helps Multi-National CIOs Select the Right Partner for International IT Rollouts (PR Newswire)
05.12.17	VolitionRx Limited to Attend Conferences in December (PR Newswire)
10.11.17	Singapore Volition signs Memorandum of Understanding with the National Taiwan University to Conduct Two Large Clinical Studies (PR Newswire)
09.11.17	VolitionRx Limited Announces Third Quarter 2017 Financial Results and Business Update (PR Newswire)
02.11.17	VolitionRx Limited Schedules Third Quarter 2017 Earnings Conference Call and Business Update (PR Newswire)
27.09.17	China Ceramics Schedules Interim Six Month 2017 Earnings Conference Call (PR Newswire)
22.09.17	VolitionRx Announces the Initial Sale of its New Nu.Q(TM) Research Kits (PR Newswire)
21.09.17	VolitionRx Limited Awarded $1.5 Million in Non-Dilutive Funding (PR Newswire)
19.09.17	VolitionRx Announces its European Colorectal Cancer Strategy (PR Newswire)
15.09.17	VolitionRx to Attend Two Major Conferences in Asia (PR Newswire)
14.09.17	Volition Granted Four Additional Patents (PR Newswire)
06.09.17	VolitionRx Limited to Attend Multiple Conferences in September (PR Newswire)
22.08.17	Volition Signs Agreement with the Institute of Laboratory Medicine of the Technical University of Munich, Germany, to assist in securing large trials in a range of cancers (PR Newswire)
09.08.17	VolitionRx Limited Announces Second Quarter 2017 Financial Results and Business Update (PR Newswire)
03.08.17	VolitionRx Limited Schedules Second Quarter 2017 Earnings Conference Call and Business Update (PR Newswire)
19.07.17	VolitionRx Limited to host a conference call regarding a 13,500 Subject Colorectal Cancer Screening Trial with the Early Detection Research Network of the U.S. National Cancer Institute (PR Newswire)
18.07.17	Volition America, Inc. Announces a Colorectal Cancer Screening Trial containing approximately 13,500 Subjects in Collaboration with the Early Detection Research Network of the U.S. National Cancer... (PR Newswire)
30.06.17	Volition to Present at the EuropaColon Advocacy Masterclass and Exhibit at the European Society for Medical Oncology Gastrointestinal Cancer Congress (PR Newswire)
27.06.17	VolitionRx Limited Corrects an Earlier Announcement (PR Newswire)
18.05.17	A new publication reports that 91% of colorectal cancers were detected at 90% specificity in a completed prospective trial using Volition's Nu.Q(TM) assays (PR Newswire)
11.05.17	VolitionRx Limited Announces First Quarter 2017 Financial Results and Business Update (PR Newswire)
09.05.17	VolitionRx Limited Announces Final Results from 8000 Patient Clinical Trial in Denmark to Evaluate the Performance of its Nu.Q(TM) Triage Test (PR Newswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Alcon	77.62	1.81 %	K V
CieFinRichemont	122.35	0.99 %	K V
Lonza Grp	531.00	0.84 %	K V
Zurich Insur Gr	553.00	0.18 %	K V
Novartis	91.93	0.00 %	K V
ABB	49.54	-0.84 %	K V
Swisscom	504.00	-0.98 %	K V
Sika	228.60	-1.12 %	K V
Holcim	88.42	-1.51 %	K V
UBS Group	27.76	-2.08 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu VolitionRX Ltd

Aktien Top/Flop

Meistgelesene Nachrichten